INTERACTION, Monitoring of Stroke Patients in Hospital and Home Environment (INTERACTION)
May 7, 2018 updated by: University of Zurich
Proof of Concept Study of the INTERACTION Technology, Monitoring of Stroke Patients in Hospital and Home Environment
Clinical assessment and monitoring of balance and arm function in stroke patients with sensor based measurement, in clinical and home environment.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
8
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Vitznau, Switzerland, 6354
- Cereneo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 99 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
subakut or chronic stroke patients
Description
Inclusion Criteria:
- Age: 18 or above
- Previous Stroke in the personal history
- Able to walk 10 meters. A walking aid (unilateral or bilateral) is permitted
- Able to walk without special shoes
- Able to raise the arm against gravity
- Able to read and understand questionnaires and able to execute commands
- Able and willing to participate in the study
- Singed Informed Consent
Exclusion Criteria:
- Contraindications on ethical grounds (vulnerable persons)
- known or suspected non-compliance, drug or alcohol abuse,
- Severe aphasia
- Severe dementia
- Severe depression
- Relevant medical disease or increased risk of rehospitalization
- Severe sensory deficits
- Severe neglect
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
proof of concept
Time Frame: 3 month
|
3 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2014
Primary Completion (Actual)
December 1, 2017
Study Completion (Actual)
December 1, 2017
Study Registration Dates
First Submitted
April 8, 2014
First Submitted That Met QC Criteria
April 15, 2014
First Posted (Estimate)
April 21, 2014
Study Record Updates
Last Update Posted (Actual)
May 8, 2018
Last Update Submitted That Met QC Criteria
May 7, 2018
Last Verified
May 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 13101
- seventh framework programme (Other Grant/Funding Number: 287351)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.